Polymers in cell encapsulation from an enveloped cell perspective

Advanced Drug Delivery Reviews

Volumn 67-68, Issue , 2014, Pages 15-34

  De Vos, Paul ^a   Lazarjani, Hamideh Aghajani ^a   Poncelet, Denis ^b   Faas, Marijke M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Universite de Nantes   (France)

Author keywords

Alginate; Biocompatibility; Biotolerability; Encapsulation; Insulin; Natural polymers; PEG; Surface properties; Synthetic polymers

Indexed keywords

ALGINATE; BIOCOMPATIBILITY; CELLS; ENCAPSULATION; INSULIN; METABOLITES; NATURAL POLYMERS; PHYSIOLOGICAL MODELS; POLYETHYLENE GLYCOLS; POLYPROPYLENE OXIDES; POLYPROPYLENES; SODIUM; SODIUM SULFATE; SURFACE PROPERTIES;

BIOTOLERABILITY; CELL ENCAPSULATIONS; CLINICAL APPLICATION; ENDOCRINE DISORDERS; FUNCTIONAL PERFORMANCE; MOLECULAR PATTERNS; NATURAL ENVIRONMENTS; SYNTHETIC POLYMERS;

CYTOLOGY;

ALGINIC ACID; CELLULOSE; CHITOSAN; COLLAGEN; GLUCURONIC ACID; HEXURONIC ACID; POLYMER; SEPHAROSE;

ANIMAL; CELL TRANSPLANTATION; CHEMISTRY; HUMAN;

ALGINATES; ANIMALS; CELL TRANSPLANTATION; CELLULOSE; CHITOSAN; COLLAGEN; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; POLYMERS; SEPHAROSE;

EID: 84898548234     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.11.005     Document Type: Review

References (336)

1. Bisceglie V.V. Uber die antineoplastische Immunitat. Z. Krebsforsch. 1933, 40:141-158.
2. Algire G.H., Weaver J.M., Prehn R.T. Growth of cells in vivo in diffusion chambers. I Survival of homografts in mice. J. Natl. Cancer Inst. 1954, 15:493-507.
3. Pareta R.A., Farney A.C., Opara E.C. Design of a bioartificial pancreas. Pathobiology 2013, 80:194-202.
4. Liu H.W., Ofosu F.A., Chang P.L. Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum. Gene Ther. 1993, 4:291-301.
5. Koo J., Chang T.S.M. Secretion of erythropoietin from microencapsulated rat kidney cells. Int. J. Artif. Organs 1993, 16:557-560.
6. Chang P.L., Shen N., Westcott A.J. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 1993, 4:433-440.
7. Cieslinski D.A., David Humes H. Tissue engineering of a bioartificial kidney. Biotechnol. Bioeng. 1994, 43:678-681.
8. Uludag H., Sefton M.V. Microencapsulated human hepatoma (HepG2) cells: in vitro growth and protein release. J. Biomed. Mater. Res. 1993, 27:1213-1224.
9. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant. 1995, 4:415-436.
10. Aebischer P., Goddard M., Signore A.P., Timpson R.L. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp. Neurol. 1994, 126:151-158.
11. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210:908-910.
12. Opara E.C., Kendall W.F. Immunoisolation techniques for islet cell transplantation. Expert. Opin. Biol. Ther. 2002, 2:503-511.
13. Uludag H., De Vos P., Tresco P.A. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 2000, 42:29-64.
14. De Vos P., Marchetti P. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol. Med. 2002, 8:363-366.
15. Wilson J.T., Chaikof E.L. Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv. Drug Deliv. Rev. 2008, 60:124-145.
16. Aebischer P., Pochon N.A.M., Heyd B., DÇglon N., Joseph J.M., Zurn A.D., Baetge E.E., Hammang J.P., Goddard M., Lysaght M., Kaplan F., Kato A.C., Schluep M., Hirt L., Regli F., Porchet F., De Tribolet N. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. Hum. Gene Ther. 1996, 7:851-860.
17. Haisch A., Groger A., Radke C., Ebmeyer J., Sudhoff H., Grasnick G., Jahnke V., Burmester G.R., Sittinger M. Macroencapsulation of human cartilage implants: pilot study with polyelectrolyte complex membrane encapsulation. Biomaterials 2000, 21:1561-1566.
18. Risbud M.V., Bhargava S., Bhonde R.R. In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: implications of low molecular weight cut-off. J. Biomed. Mater. Res. A 2003, 66:86-92.
19. Prochorov A.V., Tretjak S.I., Goranov V.A., Glinnik A.A., Goltsev M.V. Treatment of insulin dependent diabetes mellitus with intravascular transplantation of pancreatic islet cells without immunosuppressive therapy. Adv. Med. Sci. 2008, 53:240-244.
20. Sakai S., Ono T., Ijima H., Kawakami K. Control of molecular weight cut-off for immunoisolation by multilayering glycol chitosan-alginate polyion complex on alginate-based microcapsules. J. Microencapsul. 2000, 17:691-699.
21. Chia S.M., Wan A.C., Quek C.H., Mao H.Q., Xu X., Shen L., Ng M.L., Leong K.W., Yu H. Multi-layered microcapsules for cell encapsulation. Biomaterials 2002, 23:849-856.
22. Khattak S.F., Chin K.S., Bhatia S.R., Roberts S.C. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol. Bioeng. 2007, 96:156-166.
23. Granicka L.H., Migaj M., Wozniewicz B., Zawitkowska T., Tolloczko T., Werynski A., Kawiak J. Encapsulation of parathyroid cells in hollow fibers: a preliminary report. Folia Histochem. Cytobiol. 2000, 38:129-131.
24. Lee M.K., Bae Y.H. Cell transplantation for endocrine disorders. Adv. Drug Deliv. Rev. 2000, 42:103-120.
25. Machluf M., Orsola A., Boorjian S., Kershen R., Atala A. Microencapsulation of Leydig cells: a system for testosterone supplementation. Endocrinology 2003, 144:4975-4979.
26. Jacobs-Tulleneers-Thevissen D., Chintinne M., Ling Z., Gillard P., Schoonjans L., Delvaux G., Strand B.L., Gorus F., Keymeulen B., Pipeleers D. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 2013, 56(7):1605-1614. 10.1007/s00125-013-2906-0.
27. Opara E.C., McQuilling J.P., Farney A.C. Microencapsulation of pancreatic islets for use in a bioartificial pancreas. Methods Mol. Biol. 2013, 1001:261-266.
28. Dufrane D., Gianello P. Macro- or microencapsulation of pig islets to cure type 1 diabetes. World J. Gastroenterol. 2012, 18:6885-6893.
29. Santos E., Pedraz J.L., Hernandez R.M., Orive G. Therapeutic cell encapsulation: ten steps towards clinical translation. J. Control. Release 2013, 170(1):1-14.
30. Weir G.C. Islet encapsulation: advances and obstacles. Diabetologia 2013, 56(7):1458-1461.
31. Orive G., Hernandez R.M., Gascon A.R., Igartua M., Pedraz J.L. Survival of different cell lines in alginate-agarose microcapsules. Eur. J. Pharm. Sci. 2003, 18:23-30.
32. Orive G., Hernandez R.M., Rodriguez-Gascon A., Calafiore R., Chang T.M., De Vos P., Hortelano G., Hunkeler D., Lacik I., Pedraz J.L. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 2004, 22:87-92.
33. de Vos P., Spasojevic M., Faas M.M. Treatment of diabetes with encapsulated islets. Adv. Exp. Med. Biol. 2010, 670:38-53.
34. Fiorina P., Folli F., Maffi P., Placidi C., Venturini M., Finzi G., Bertuzzi F., Davalli A., D'Angelo A., Socci C., Gremizzi C., Orsenigo E., La Rosa S., Ponzoni M., Cardillo M., Scalamogna M., Del Maschio A., Capella C., Di Carlo V., Secchi A. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation 2003, 75:1296-1301.
35. Hansen M.V., Pedersen-Bjergaard U., Heller S.R., Wallace T.M., Rasmussen A.K., Jorgensen H.V., Pramming S., Thorsteinsson B. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res. Clin. Pract. 2009, 85:183-188.
36. Juang J.H. Islet transplantation: an update. Chang Gung Med. J. 2004, 27:1-15.
37. De Haan B.J., Faas M.M., De Vos P. Factors influencing insulin secretion from encapsulated islets. Cell Transplant. 2003, 12:617-625.
38. De Vos P., De Haan B.J., Wolters G.H.J., Strubbe J.H., Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 1997, 40:262-270.
39. De Vos P., Vegter D., De Haan B.J., Strubbe J.H., Bruggink J.E., Van Schilfgaarde R. Kinetics of intraperitoneally infused insulin in rats: functional implications for the bioartificial pancreas. Diabetes 1996, 45:1102-1107.
40. Jansson P.A., Fowelin J.P., Von Schenck H.P., Smith U.P., LÔnnroth P.N. Measurement by microdialysis of insulin concentration in subcutaneous interstitial fluid. Diabetes 1993, 42:1469-1473.
41. De Vos P., De Haan B.J., Vegter D., Hillebrands J.L., Strubbe J.H., Bruggink J.E., Van Schilfgaarde R. Insulin levels after portal and systemic insulin infusion differ in a dose-dependent fashion. Horm. Metab. Res. 1998, 30:721-725.
42. Tatarkiewicz K., Garcia M., Omer A., Van Schilfgaarde R., Weir G.C., De Vos P. C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets. Diabetologia 2001, 44:646-653.
43. De Vos P., van Straaten J.F., Nieuwenhuizen A.G., de Groot M., Ploeg R.J., De Haan B.J., Van Schilfgaarde R. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?. Diabetes 1999, 48:1381-1388.
44. Orive G., Gascon A.R., Hernandez R.M., Igartua M., Luis-Pedraz J. Cell microencapsulation technology for biomedical purposes: novel insights and challenges. Trends Pharmacol. Sci. 2003, 24:207-210.
45. Cornolti R., Figliuzzi M., Remuzzi A. Effect of micro- and macroencapsulation on oxygen consumption by pancreatic islets. Cell Transplant. 2009, 18:195-201.
46. Carlsson P.O., Palm F., Andersson A., Liss P. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 2000, 69:761-766.
47. Brand M.D., Affourtit C., Esteves T.C., Green K., Lambert A.J., Miwa S., Pakay J.L., Parker N. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic. Biol. Med. 2004, 37:755-767.
48. Bodziony J. Bioartificial endocrine pancreas: foreign-body reaction and effectiveness of diffusional transport of insulin and oxygen after long-term implantation of hollow fibers into rats. Res. Exp. Med. Berl. 1992, 192:305-316.
49. Ludwig B., Rotem A., Schmid J., Weir G.C., Colton C.K., Brendel M.D., Neufeld T., Block N.L., Yavriyants K., Steffen A., Ludwig S., Chavakis T., Reichel A., Azarov D., Zimermann B., Maimon S., Balyura M., Rozenshtein T., Shabtay N., Vardi P., Bloch K., de Vos P., Schally A.V., Bornstein S.R., Barkai U. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5022-5027.
50. Dionne K.E., Colton C.K., Yarmush M.L. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993, 42:12-21.
51. Carlsson P.O., Palm F. Oxygen tension in isolated transplanted rat islets and in islets of rat whole-pancreas transplants. Transpl. Int. 2002, 15:581-585.
52. Mueller-Klieser W., Freyer J.P., Sutherland R.M. Influence of glucose and the oxygen supply conditions on the oxygenation of multicellular spheroids. Br. J. Cancer 1986, 53:345-353.
53. Renvall S., Niinikoski J. Intraperitoneal oxygen and carbon dioxide tensions in experimental adhesion disease and peritonitis. Am. J. Surg. 1975, 130:286-292.
54. Smink A.M., Faas M.M., de Vos P. Toward engineering a novel transplantation site for human pancreatic islets. Diabetes 2013, 62:1357-1364.
55. De Vos P., Van Hoogmoed C.G., van Zanten J., Netter S., Strubbe J.H., Busscher H.J. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials 2003, 24:305-312.
56. van Suylichem P.T., Strubbe J.H., Houwing H., Wolters G.H., Van Schilfgaarde R. Insulin secretion by rat islet isografts of a defined endocrine volume after transplantation to three different sites. Diabetologia 1992, 35:917-923.
57. Pipeleers D., Ling Z. Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab. Rev. 1992, 8:209-227.
58. van Suylichem P.T., Strubbe J.H., Houwing H., Wolters G.H., Van Schilfgaarde R. Rat islet isograft function. Effect of graft volume and transplantation site. Transplantation 1994, 57:1010-1017.
59. Fritschy W.M., De Vos P., Groen H., Klatter F.A., Pasma A., Wolters G.H., Van Schilfgaarde R. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transpl. Int. 1994, 7:264-271.
60. Hirsiger S., Simmen H.P., Werner C.M., Wanner G.A., Rittirsch D. Danger signals activating the immune response after trauma. Mediators Inflamm. 2012, 2012:315941.
61. Kaczmarek A., Vandenabeele P., Krysko D.V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38:209-223.
62. Pittman K., Kubes P. Damage-associated molecular patterns control neutrophil recruitment. J. Innate Immun. 2013, 5(4):315-323.
63. Tang D., Kang R., Coyne C.B., Zeh H.J., Lotze M.T. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol. Rev. 2012, 249:158-175.
64. Santos E., Zarate J., Orive G., Hernandez R.M., Pedraz J.L. Biomaterials in cell microencapsulation. Adv. Exp. Med. Biol. 2010, 670:5-21.
65. Rokstad A.M., Holtan S., Strand B., Steinkjer B., Ryan L., Kulseng B., Skjak-Braek G., Espevik T. Microencapsulation of cells producing therapeutic proteins: optimizing cell growth and secretion. Cell Transplant. 2002, 11:313-324.
66. Langlois G., Dusseault J., Bilodeau S., Tam S.K., Magassouba D., Halle J.P. Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. Acta Biomater. 2009, 5:3433-3440.
67. Orive G., Tam S.K., Pedraz J.L., Halle J.P. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials 2006, 27:3691-3700.
68. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
69. Rokstad A.M., Lacik I., de Vos P., Strand B.L. Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation. Adv. Drug Deliv. Rev. 2014, 67-68:111-130.
70. Hilborn J., Bjursten L.M. A new and evolving paradigm for biocompatibility. J. Tissue. Eng. Regen. Med. 2007, 1:110-119.
71. Lacík I. Polymer chemistry in diabetes treatment by encapsulated islets of langerhans: review to 2006. Aust. J. Chem. 2006, 59:508-524.
72. de Vos P., Bucko M., Gemeiner P., Navratil M., Svitel J., Faas M., Strand B.L., Skjak-Braek G., Morch Y.A., Vikartovska A., Lacik I., Kollarikova G., Orive G., Poncelet D., Pedraz J.L., Ansorge-Schumacher M.B. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009, 30:2559-2570.
73. Rokstad A.M., Brekke O.L., Steinkjer B., Ryan L., Kollarikova G., Strand B.L., Skjak-Braek G., Lacik I., Espevik T., Mollnes T.E. Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater. 2011, 7:2566-2578.
74. Prakash S., Chang T.M.S. Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal. Biotechnol. Bioeng. 1995, 46:621-626.
75. Nafea E.H., Marson A., Poole-Warren L.A., Martens P.J. Immunoisolating semi-permeable membranes for cell encapsulation: focus on hydrogels. J. Control. Release 2011, 154:110-122.
76. Li R.H. Materials for immunoisolated cell transplantation. Adv. Drug Deliv. Rev. 1998, 33:87-109.
77. Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv. Mater. 2009, 21:3307-3329.
78. de Vos P., Spasojevic M., Faas M.M. Treatment of diabetes with encapsulated islets. Adv Exp Med Biol. 2010, 670:38-53.
79. Li A.A., Shen F., Zhang T., Cirone P., Potter M., Chang P.L. Enhancement of myoblast microencapsulation for gene therapy. J. Biomed. Mater. Res. B Appl. Biomater. 2006, 77:296-306.
80. Zhang Y., Wang W., Zhou J., Yu W., Zhang X., Guo X., Ma X. Tumor anti-angiogenic gene therapy with microencapsulated recombinant CHO cells. Ann. Biomed. Eng. 2007, 35:605-614.
81. Leung A., Ramaswamy Y., Munro P., Lawrie G., Nielsen L., Trau M. Emulsion strategies in the microencapsulation of cells: pathways to thin coherent membranes. Biotechnol. Bioeng. 2005, 92:45-53.
82. Okada N., Miyamoto H., Yoshioka T., Katsume A., Saito H., Yorozu K., Ueda O., Itoh N., Mizuguchi H., Nakagawa S., Ohsugi Y., Mayumi T. Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane. Biochim. Biophys. Acta 1997, 1360:53-63.
83. Leung A., Lawrie G., Nielsen L.K., Trau M. Synthesis and characterization of alginate/poly-l-ornithine/alginate microcapsules for local immunosuppression. J. Microencapsul. 2008, 25:387-398.
84. Miyamoto H., Okada N., Yoshioka T., Suzuki R., Sakamoto K., Katsume A., Saito H., Tsutsumi Y., Kubo K., Nakagawa S., Ohsugi Y., Mayumi T. Prolongation of the effective duration of cytomedical therapy by re-injecting SK2 hybridoma cells microencapsulated within alginate-poly(l)lysine-alginate membranes into human interleukin-6 transgenic mice. Biol. Pharm. Bull. 1999, 22:295-297.
85. Bruni S., Chang T.M. Hepatocytes immobilised by microencapsulation in artificial cells: effects on hyperbilirubinemia in Gunn rats. Biomater. Artif. Cells Artif. Organs 1989, 17:403-411.
86. Fu X.W., Sun A.M. Microencapsulated parathyroid cells as a bioartificial parathyroid. In vivo studies. Transplantation 1989, 47:432-435.
87. Wee S., Gombotz W.R. Protein release from alginate matrices. Adv. Drug Deliv. Rev. 1998, 31:267-285.
88. Stokke B.T., Smidsroed O., Bruheim P., Skjaak-Braek G. Distribution of uronate residues in alginate chains in relation to alginate gelling properties. Macromolecules 1991, 24:4637-4645.
89. 2+ on alginate microbeads. Biomacromolecules 2006, 7:1471-1480.
90. Teramura Y., Oommen O.P., Olerud J., Hilborn J., Nilsson B. Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multifunctional crosslinkers. Biomaterials 2013, 34:2683-2693.
91. Lanza R.P., Ecker D., KÅhtreiber W.M., Staruk J.E., Marsh J., Chick W.L. A simple method for transplanting discordant islets into rats using alginate gel spheres. Transplantation 1995, 59:1485-1487.
92. Horcher A., Zekorn T., Siebers U., KlÔck G., Frank H., Houben R., Bretzel R.G., Zimmermann U., Federlin K. Transplantation of microencapsulated islets in rats: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules. Transplant. Proc. 1994, 26:784-786.
93. De Vos P., Andersson A., Tam S.K., Faas M.M., Halle J.P. Advances and barriers in mammalian cell encapsulation for treatment of diabetes. Immunol. Endocr. Metab. Agents Med. Chem. 2006, 139-153.
94. Wang T., Lacík I., Brissová M., Anilkumar A.V., Prokop A., Hunkeler D., Green R., Shahrokhi K., Powers A.C. An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 1997, 15:358-362.
95. Bartkowiak A., Canaple L., Ceausoglu I., Nurdin N., Renken A., Rindisbacher L., Wandrey C., Desvergne B., Hunkeler D. New multicomponent capsules for immunoisolation. Ann. N. Y. Acad. Sci. 1999, 875. (vol.).
96. Calafiore R., Pietropaolo M., Basta G., Falorni A., Picchio M.L., Brunetti P. Pancreatic beta-cell destruction in non-obese diabetic mice. Metabolism 1993, 42:854-859.
97. De Vos P., De Haan B., Van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 1997, 18:273-278.
98. Basta G., Sarchielli P., Luca G., Racanicchi L., Nastruzzi C., Guido L., Mancuso F., Macchiarulo G., Calabrese G., Brunetti P., Calafiore R. Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus. Transpl. Immunol. 2004, 13:289-296.
99. Chandy T., Mooradian D.L., Rao G.H. Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif. Organs 1999, 23:894-903.
100. Sobol M., Bartkowiak A., de Haan B., de Vos P. Cytotoxicity study of novel water-soluble chitosan derivatives applied as membrane material of alginate microcapsules. J. Biomed. Mater. Res. A 2013, 101(7):1907-1914.
101. Orive G., Hernandez R.M., Gascon A.R., Igartua M., Rojas A., Pedraz J.L. Microencapsulation of an anti-VE-cadherin antibody secreting 1B5 hybridoma cells. Biotechnol. Bioeng. 2001, 76:285-294.
102. Lacik I., Anilkumar A.V., Wang T.G. A two-step process for controlling the surface smoothness of polyelectrolyte-based microcapsules. J. Microencapsul. 2001, 18:479-490.
103. Spasojevic M., Bhujbal S., Paredes G., de Haan B.J., Schouten A.J., de Vos P. Considerations in binding diblock copolymers on hydrophilic alginate beads for providing an immunoprotective membrane. J. Biomed. Mater. Res. A 2013, (in press). 10.1002/jbm.a.34863.
104. Lu M.Z., Lan H.L., Wang F.F., Chang S.J., Wang Y.J. Cell encapsulation with alginate and alpha-phenoxycinnamylidene-acetylated poly(allylamine). Biotechnol. Bioeng. 2000, 70:479-483.
105. Wikstrom J., Syvajarvi H., Urtti A., Yliperttula M. Kinetic simulation model of protein secretion and accumulation in the cell microcapsules. J. Gene Med. 2008, 10:575-582.
106. O'Shea G.M., Sun A.M. Encapsulation of rat islets of langerhans prolongs xenograft survival in diabetic mice. Diabetes 1986, 35:943-946.
107. Chen J.-P., Chu I.M., Shiao M.-Y., Hsu B.R.-S., Fu S.-H. Microencapsulation of islets in PEG-amine modified alginate-poly(l-lysine)-alginate microcapsules for constructing bioartificial pancreas. J. Ferment. Bioeng. 1998, 86:185-190.
108. Chen J.P., Chu I.M., Shiao M.Y., Hsu B.R., Fu S.H. Microencapsulation of islets in PEG-amine modified alginate-poly(L-lysine)-alginate microcapsules for constructing bioartificial pancreas. J. Ferment. Bioeng. 1998, 86:185-190.
109. Desai N.P., Sojomihardjo A., Yao Z., Ron N., Soon-Shiong P. Interpenetrating polymer networks of alginate and polyethylene glycol for encapsulation of islets of Langerhans. J. Microencapsul. 2000, 17:677-690.
110. Breguet V., Gugerli R., Pernetti M., von Stockar U., Marison I.W. Formation of microcapsules from polyelectrolyte and covalent interactions. Langmuir 2005, 21:9764-9772.
111. Dusseault J., Leblond F.A., Robitaille R., Jourdan G., Tessier J., Menard M., Henley N., Halle J.P. Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers. Biomaterials 2005, 26:1515-1522.
112. Gattas-Asfura K.M., Stabler C.L. Chemoselective cross-linking and functionalization of alginate via Staudinger ligation. Biomacromolecules 2009, 10:3122-3129.
113. Gattas-Asfura K.M., Stabler C.L. Chemoselective cross-linking and functionalization of alginate via Staudinger ligation. Biomacromolecules 2009, 10:3122-3129.
114. 2. Biomacromolecules 2007, 8:2622-2626.
115. Sakai S., Kawakami K. Synthesis and characterization of both ionically and enzymatically cross-linkable alginate. Acta Biomater. 2007, 3:495-501.
116. Klock G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., Wohrle M., Federlin K., Zimmermann U. Production of purified alginates suitable for use in immunoisolated transplantation. Appl. Microbiol. Biotechnol. 1994, 40:638-643.
117. Kumar S., Ingle H., Prasad D.V., Kumar H. Recognition of bacterial infection by innate immune sensors. Crit. Rev. Microbiol. 2013, 39(3). 229-146.
118. Rokstad A.M., Brekke O.L., Steinkjer B., Ryan L., Kollarikova G., Strand B.L., Skjak-Braek G., Lambris J.D., Lacik I., Mollnes T.E., Espevik T. The induction of cytokines by polycation containing microspheres by a complement dependent mechanism. Biomaterials 2013, 34:621-630.
119. Rokstad A.M., Brekke O.L., Steinkjer B., Ryan L., Kollarikova G., Strand B.L., Skjak-Braek G., Lacik I., Espevik T., Mollnes T.E. Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater. 2011, 7:2566-2578.
120. Tam K.T., Dusseault J., Polizu S., MÇnard M., HallÇ J.P., L'Hocine Y. Physicochemical model of alginate-poly-l-lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS. Biomaterials 2005, 6950-6961.
121. Bunger C.M., Tiefenbach B., Jahnke A., Gerlach C., Freier T., Schmitz K.P., Hopt U.T., Schareck W., Klar E., De Vos P. Deletion of the tissue response against alginate-pll capsules by temporary release of co-encapsulated steroids. Biomaterials 2005, 26:2353-2360.
122. Bunger C.M., Gerlach C., Freier T., Schmitz K.P., Pilz M., Werner C., Jonas L., Schareck W., Hopt U.T., De Vos P. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J. Biomed. Mater. Res. 2003, 67A:1219-1227.
123. de Vos P., Spasojevic M., de Haan B.J., Faas M.M. The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules. Biomaterials 2012, 33:5552-5559.
124. De Vos P., De Haan B.J., Kamps J.A., Faas M.M., Kitano T. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility?. J. Biomed. Mater. Res. A 2007, 80:813-819.
125. Scheirer W., Nilsson K., Merten O.W., Katinger H.W., Mosbach K. Entrapment of animal cells for the production of biomolecules such as monoclonal antibodies. Dev. Biol. Stand. 1983, 55:155-161.
126. Yang H., Zhao K., Ye Y., Deng S. Study of macroencapsulated islet xenografts for treatment of diabetes in mice. Hua Xi Yi Ke Da Xue Xue Bao 1998, 29:132-135.
127. Jain K., Yang H., Cai B.R., Haque B., Hurvitz A.I., Diehl C., Miyata T., Smith B.H., Stenzel K., Suthanthiran M., et al. Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression. Transplantation 1995, 59:319-324.
128. Miyoshi Y., Date I., Ohmoto T., Iwata H. Histological analysis of microencapsulated dopamine-secreting cells in agarose/poly(styrene sulfonic acid) mixed gel xenotransplanted into the brain. Exp. Neurol. 1996, 138:169-175.
129. Orive G., Hernandez R.M., Gascon A.R., Igartua M., Pedraz J.L. Survival of different cell lines in alginate-agarose microcapsules. Eur. J. Pharm. Sci. 2003, 18:23-30.
130. Sakai S., Hashimoto I., Kawakami K. Agarose-gelatin conjugate for adherent cell-enclosing capsules. Biotechnol. Lett. 2007, 29:731-735.
131. Okada N., Miyamoto H., Yoshioka T., Katsume A., Saito H., Yorozu K., Ueda O., Nakagawa S., Ohsugi Y., Mayumi T. Therapeutic effect of cytomedicine on mesangio-proliferative glomerulonephritis in human interleukin-6 transgenic mice. Biol. Pharm. Bull. 1997, 20:255-258.
132. Inoue K., Gu Y.J., Hayashi H., Shinohara S., Aung T., Tun T., Wang W.J., Setoyama H., Kawakami Y., Kaji H., Imamura M., Morikawa N., Iwata H., Ikada Y. Pig-to-rat xenotransplantation with mesh-reinforced polyvinyl alcohol bag: efficacy of agarose gel. Transplant. Proc. 1996, 28:1422-1423.
133. Kai-Chiang Y., Ching-Yao Y., Chang-Chin W., Tzong-Fu K., Feng-Huei L. In vitro study of using calcium phosphate cement as immunoisolative device to enclose insulinoma/agarose microspheres as bioartificial pancreas. Biotechnol. Bioeng. 2007, 98:1288-1295.
134. Iwata H., Amemiya H., Matsuda T., Takano H., Hayashi R., Akutsu T. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes 1989, 38(Suppl. 1):224-225.
135. Fernandez-Cossio S., Leon-Mateos A., Sampedro F.G., Oreja M.T. Biocompatibility of agarose gel as a dermal filler: histologic evaluation of subcutaneous implants. Plast. Reconstr. Surg. 2007, 120:1161-1169.
136. Gin H., Dupuy B., Baquey C., Ducassou D., Aubertin J. Agarose encapsulation of islets of Langerhans: reduced toxicity in vitro. J. Microencapsul. 1987, 4:239-242.
137. Sakai S., Kawabata K., Ono T., Ijima H., Kawakami K. Development of mammalian cell-enclosing subsieve-size agarose capsules (<100microm) for cell therapy. Biomaterials 2005, 26:4786-4792.
138. Kobayashi T., Aomatsu Y., Iwata H., Kin T., Kanehiro H., Hisanaga M., Ko S., Nagao M., Nakajima Y. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation 2003, 75:619-625.
139. Kobayashi T., Aomatsu Y., Kanehiro H., Hisanaga M., Nakajima Y. Protection of NOD islet isograft from autoimmune destruction by agarose microencapsulation. Transplant. Proc. 2003, 35:484-485.
140. Tashiro H., Iwata H., Warnock G.L., Takagi T., Machida H., Ikada Y., Tsuji T. Characterization and transplantation of agarose microencapsulated canine islets of Langerhans. Ann. Transplant. 1997, 2:33-39.
141. Tashiro H., Iwata H., Warnock G.L., Ikada Y., Tsuji T. Viability studies of agarose microencapsulated islets of Langerhans from dogs. Transplant. Proc. 1998, 30:490.
142. Iwata H., Takagi T., Amemiya H. Agarose microcapsule applied in islet xenografts (hamster to mouse). Transplant. Proc. 1992, 24:952.
143. Iwata H., Takagi T., Amemiya H., Shimizu H., Yamashita K., Kobayashi K., Akutsu T. Agarose for a bioartificial pancreas. J. Biomed. Mater. Res. 1992, 26:967-977.
144. Iwata H., Kobayashi K., Takagi T., Oka T., Yang H., Amemiya H., Tsuji T., Ito F. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J. Biomed. Mater. Res. 1994, 28:1003-1011.
145. Dupuy B., Gin H., Baquey C., Ducassou D. In situ polymerization of a microencapsulating medium round living cells. J. Biomed. Mater. Res. 1988, 22:1061-1070.
146. Gin H., Dupuy B., Baquey A., Baquey C.H., Ducassou D. Lack of responsiveness to glucose of microencapsulated islets of Langerhans after three weeks' implantation in the rat - influence of the complement. J. Microencapsul. 1990, 7:341-346.
147. Tun T., Inoue K., Hayashi H., Aung T., Gu Y.J., Doi R., Kaji H., Echigo Y., Wang W.J., Setoyama H., Imamura M., Maetani S., Morikawa N., Iwata H., Ikada Y. A newly developed three-layer agarose microcapsule for a promising biohybrid artificial pancreas: rat to mouse xenotransplantation. Cell Transplant. 1996, 5:S59-S63.
148. Jain K., Yang H., Asina S.K., Patel S.G., Desai J., Diehl C., Stenzel K., Smith B.H., Rubin A.L. Long-term preservation of islets of Langerhans in hydrophilic macrobeads. Transplantation 1996, 61:532-536.
149. Jain K., Yang H., Cai B.R., Haque B., Hurvitz A.I., Diehl C., Miyata T., Smith B.H., Stenzel K. Suthanthiran et al. Long-term preservation of islets of Langerhans in hydrophilic macrobeads, Transplantation 1996, 61:532-536.
150. Y.H., Jain K., Cai B.R., Haque B., Hurvitz A.I., Diehl C., Miyata T., Smith B.H., Stenzel K., Suthanthiran M., et al. Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression. Transplantation 1995, 59:319-324.
151. Wang W., Gu Y., Tabata Y., Miyamoto M., Hori H., Nagata N., Touma M., Balamurugan A.N., Kawakami Y., Nozawa M., Inoue K. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 2002, 73:122-129.
152. Iwata H., Kobayashi K., Takagi T., Oka T., Yang H., Amemiya H., Tsuji T., Ito F. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J. Biomed. Mater. Res. 1994, 28:1003-1011.
153. Iwata H., Takagi T., Kobayashi K., Oka T., Tsuji T., Ito F. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J. Biomed. Mater. Res. 1994, 28:1201-1207.
154. Iwata H., Takagi T., Kobayashi K., Yang H., Ito F. Immunoisolative effectiveness and limitation of agarose in a bioartificial pancreas. Transplant. Proc. 1994, 26:789.
155. Gin H., Dupuy B., Baquey C., Ducassou D., Aubertin J. Agarose encapsulation of islets of Langerhans: reduced toxicity in vitro. J. Microencapsul. 1987, 4:239-242.
156. Sakai S., Hashimoto I., Kawakami K. Agarose-gelatin conjugate for adherent cell-enclosing capsules. Biotechnol. Lett. 2007, 29:731-735.
157. Emerich D.F., Hammang J.P., Baetge E.E., Winn S.R. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. 1994, 130:141-150.
158. Chia S.M., Leong K.W., Li J., Xu X., Zeng K., Er P.N., Gao S., Yu H. Hepatocyte encapsulation for enhanced cellular functions. Tissue Eng. 2000, 6:481-495.
159. Aebischer P., Buchser E., Joseph J.M., Favre J., De Tribolet N., Lysaght M., Rudnick S., Goddard M. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression: a preliminary report. Transplantation 1994, 58:1275-1277.
160. Zielinski B.A., Aebischer P. Chitosan as a matrix for mammalian cell encapsulation. Biomaterials 1994, 15:1049-1056.
161. Sagot Y., Tan S.A., Baetge E., Schmalbruch H., Kato A.C., Aebischer P. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 1995, 7:1313-1322.
162. Kanczler J.M., Sura H.S., Magnay J., Green D., Oreffo R.O., Dobson J.P., El Haj A.J. Controlled differentiation of human bone marrow stromal cells using magnetic nanoparticle technology. Tissue Eng. Part A 2010, 16:3241-3250.
163. Rask F., Dallabrida S.M., Ismail N.S., Amoozgar Z., Yeo Y., Rupnick M.A., Radisic M. Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. J. Biomed. Mater. Res. A 2010, 95:105-117.
164. Baruch L., Machluf M. Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability. Biopolymers 2006, 82:570-579.
165. VandeVord P.J., Matthew H.W., DeSilva S.P., Mayton L., Wu B., Wooley P.H. Evaluation of the biocompatibility of a chitosan scaffold in mice. J. Biomed. Mater. Res. 2002, 59:585-590.
166. Zhang M., Li X.H., Gong Y.D., Zhao N.M., Zhang X.F. Properties and biocompatibility of chitosan films modified by blending with PEG. Biomaterials 2002, 23:2641-2648.
167. Azab A.K., Doviner V., Orkin B., Kleinstern J., Srebnik M., Nissan A., Rubinstein A. Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat. J. Biomed. Mater. Res. A 2007, 83:414-422.
168. Jenkins D.W., Hudson S.M. Review of vinyl graft copolymerization featuring recent advances toward controlled radical-based reactions and illustrated with chitin/chitosan trunk polymers. Chem. Rev. 2001, 101:3245-3273.
169. Hudson S.M., Jenkins D.W. Chitin and Chitosan 2002, John Wiley & Sons Inc.
170. Kim H.J., Lee H.C., Oh J.S., Shin B.A., Oh C.S., Park R.D., Yang K.S., Cho C.S. Polyelectroylte complex composed of chitosan and sodium alginate for wound dressing application. J. Biomater. Sci. Polym. Ed. 1999, 10:543-556.
171. Skaugrud O., Hagen A., Borgersen B., Dornish M. Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnol. Genet. Eng. Rev. 1999, 16:23-40.
172. Yang K.C., Wu C.C., Cheng Y.H., Kuo T.F., Lin F.H. Chitosan/gelatin hydrogel prolonged the function of insulinoma/agarose microspheres in vivo during xenogenic transplantation. Transplant. Proc. 2008, 40:3623-3626.
173. Kubota N., Tatsumoto N., Sano T., Toya K. A simple preparation of half N-acetylated chitosan highly soluble in water and aqueous organic solvents. Carbohydr. Res. 2000, 324:268-274.
174. Gupta S., Kim S.K., Vemuru R.P., Aragona E., Yerneni P.R., Burk R.D., Rha C.K. Hepatocyte transplantation: an alternative system for evaluating cell survival and immunoisolation. Int. J. Artif. Organs 1993, 16:155-163.
175. Zhu J.H., Wang X.W., Ng S., Quek C.H., Ho H.T., Lao X.J., Yu H. Encapsulating live cells with water-soluble chitosan in physiological conditions. J. Biotechnol. 2005, 117:355-365.
176. Lee B.R., Lee K.H., Kang E., Kim D.S., Lee S.H. Microfluidic wet spinning of chitosan-alginate microfibers and encapsulation of HepG2 cells in fibers. Biomicrofluidics 2011, 5:22208.
177. Ruel-Gariepy E., Leclair G., Hildgen P., Gupta A., Leroux J.C. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J. Control. Release 2002, 82:373-383.
178. Sobol M., Bartkowiak A., de Haan B., de Vos P. Cytotoxicity study of novel water-soluble chitosan derivatives applied as membrane material of alginate microcapsules. J. Biomed. Mater. Res. A 2013, 101:1907-1914.
179. Haque T., Chen H., Ouyang W., Martoni C., Lawuyi B., Urbanska A.M., Prakash S. In vitro study of alginate-chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failure. Biotechnol. Lett. 2005, 27:317-322.
180. Gaserod O., Smidsrod O., Skjak-Braek G. Microcapsules of alginate-chitosan - I. A quantitative study of the interaction between alginate and chitosan. Biomaterials 1998, 19:1815-1825.
181. Gaserod O., Sannes A., Skjak-Braek G. Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability. Biomaterials 1999, 20:773-783.
182. Karle P., Muller P., Renz R., Jesnowski R., Saller R., von Rombs K., Nizze H., Liebe S., Gunzburg W.H., Salmons B., Lohr M. Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy. Adv. Exp. Med. Biol. 1998, 451:97-106.
183. Dautzenberg H., Schuldt U., Grasnick G., Karle P., Muller P., Lohr M., Pelegrin M., Piechaczyk M., Rombs K.V., Gunzburg W.H., Salmons B., Saller R.M. Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Ann. N. Y. Acad. Sci. 1999, 875:46-63.
184. 2+ scaffold. J. Biotechnol. 2004, 114:315-326.
185. Schaffellner S., Stadlbauer V., Stiegler P., Hauser O., Halwachs G., Lackner C., Iberer F., Tscheliessnigg K.H. Porcine islet cells microencapsulated in sodium cellulose sulfate. Transplant. Proc. 2005, 37:248-252.
186. Stadlbauer V., Stiegler P.B., Schaffellner S., Hauser O., Halwachs G., Iberer F., Tscheliessnigg K.H., Lackner C. Morphological and functional characterization of a pancreatic beta-cell line microencapsulated in sodium cellulose sulfate/poly(diallyldimethylammonium chloride). Xenotransplantation 2006, 13:337-344.
187. Lohr M., Bago Z.T., Bergmeister H., Ceijna M., Freund M., Gelbmann W., Gunzburg W.H., Jesnowski R., Hain J., Hauenstein K., Henninger W., Hoffmeyer A., Karle P., Kroger J.C., Kundt G., Liebe S., Losert U., Muller P., Probst A., Puschel K., Renner M., Renz R., Saller R., Salmons B., Walter I., et al. Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study. J. Mol. Med. (Berl) 1999, 77:393-398.
188. Pelegrin M., Marin M., Noel D., Del Rio M., Saller R., Stange J., Mitzner S., Gunzburg W.H., Piechaczyk M. Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Ther. 1998, 5:828-834.
189. Pelegrin M., Marin M., Oates A., Noel D., Saller R., Salmons B., Piechaczyk M. Immunotherapy of a viral disease by in vivo production of therapeutic monoclonal antibodies. Hum. Gene Ther. 2000, 11:1407-1415.
190. Ikeda H., Kobayashi N., Tanaka Y., Nakaji S., Yong C., Okitsu T., Oshita M., Matsumoto S., Noguchi H., Narushima M., Tanaka K., Miki A., Rivas-Carrillo J.D., Soto-Gutierrez A., Navarro-Alvarez N., Jun H.S., Tanaka N., Yoon J.W. A newly developed bioartificial pancreas successfully controls blood glucose in totally pancreatectomized diabetic pigs. Tissue Eng. 2006, 12:1799-1809.
191. Miyamoto T., Takahashi S., Ito H., Inagaki H., Noishiki Y. Tissue biocompatibility of cellulose and its derivatives. J. Biomed. Mater. Res. 1989, 23:125-133.
192. Canaple L., Rehor A., Hunkeler D. Improving cell encapsulation through size control. J. Biomater. Sci. Polym. Ed. 2002, 13:783-796.
193. Nishiyama Y., Sugiyama J., Chanzy H., Langan P. Crystal structure and hydrogen bonding system in cellulose I(alpha) from synchrotron X-ray and neutron fiber diffraction. J. Am. Chem. Soc. 2003, 125:14300-14306.
194. Matthew H.W., Salley S.O., Peterson W.D., Klein M.D. Complex coacervate microcapsules for mammalian cell culture and artificial organ development. Biotechnol. Prog. 1993, 9:510-519.
195. Stadlbauer V., Stiegler P.B., Schaffellner S., Hauser O., Halwachs G., Iberer F., Tscheliessnigg K.H., Lackner C. Morphological and functional characterization of a pancreatic β-cell line microencapsulated in sodium cellulose sulfate/poly(diallyldimethylammonium chloride). Xenotransplantation 2006, 13:337-344.
196. Dautzenberg H., Schuldt U.T.E., Grasnick G., Karle P., MÜLler P., LÖHr M., Pelegrin M., Piechaczyk M., Rombs K.V., GÜNzburg W.H., Salmons B., Saller R.M. Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Ann. N. Y. Acad. Sci. 1999, 875:46-63.
197. Kim K., Liu X., Zhang Y., Cheng J., Yu W.X., Sun Y. Elastic and viscoelastic characterization of microcapsules for drug delivery using a force-feedback MEMS microgripper. Biomed. Microdevices 2009, 11(2):421-427.
198. Chen Huangqin, Fan Mingwen Novel thermally sensitive pH-dependent chitosan/carboxymethyl cellulose hydrogels. J. Bioact. Compat. Polym. 2008, 23:38-48.
199. Ogushi Y., Sakai S., Kawakami K. Synthesis of enzymatically-gellable carboxymethylcellulose for biomedical applications. J. Biosci. Bioeng. 2007, 104:30-33.
200. Sakai S., Mu C., Kawabata K., Hashimoto I., Kawakami K. Biocompatibility of subsieve-size capsules versus conventional-size microcapsules. J. Biomed. Mater. Res. 2006, 78A:394-398.
201. Sakai S., Ito S., Ogushi Y., Hashimoto I., Kawakami K. Feasibility of carboxymethylcellulose with phenol moieties as a material for mammalian cell-enclosing subsieve-size capsules. Cellulose 2008, 15:723-729.
202. Helenius G., Backdahl H., Bodin A., Nannmark U., Gatenholm P., Risberg B. In vivo biocompatibility of bacterial cellulose. J. Biomed. Mater. Res. A 2006, 76:431-438.
203. Brissová M., Lacík I., Powers A.C., Anilkumar A.V., Wang T. Control and measurement of permeability for design of microcapsule cell delivery system. J. Biomed. Mater. Res. 1998, 39:61-70.
204. Lacik I., Brissová M., Anilkumar A.V., Powers A.C., Wang T. New capsule with tailored properties for the encapsulation of living cells. J. Biomed. Mater. Res. 1998, 39:52-60.
205. Schneider S., Feilen P.J., Slotty V., Kampfner D., Preuss S., Berger S., Beyer J., Pommersheim R. Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets. Biomaterials 2001, 22:1961-1970.
206. Yin C., Chia S.M., Quek C.H., Yu H., Zhuo R.X., Leong K.W., Mao H.Q. Microcapsules with improved mechanical stability for hepatocyte culture. Biomaterials 2003, 24:1771-1780.
207. Wu F.J., Friend J.R., Lazar A., Mann H.J., Remmel R.P., Cerra F.B., Hu W.S. Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. Biotechnol. Bioeng. 1996, 52:34-44.
208. Lahooti S., Sefton M.V. Microencapsulation of normal and transfected L929 fibroblasts in a HEMA-MMA copolymer. Tissue Eng. 2000, 6:139-149.
209. Lee C.H., Singla A., Lee Y. Biomedical applications of collagen. Int. J. Pharm. 2001, 221:1-22.
210. Traub W., Piez K.A. The chemistry and structure of collagen. Adv. Protein Chem. 1971, 25:243-352.
211. Perez C.M., Panitch A., Chmielewski J. A collagen peptide-based physical hydrogel for cell encapsulation. Macromol. Biosci. 2011, 11:1426-1431.
212. Ramachandran G. Molecular structure of collagen. Int. Rev. Connect. Tissue Res. 1963, 1:127-182.
213. Parenteau-Bareil R., Gauvin R., Cliche S., Gariepy C., Germain L., Berthod F. Comparative study of bovine, porcine and avian collagens for the production of a tissue engineered dermis. Acta Biomater. 2011, 7:3757-3765.
214. Chia S.M., Wan A.C., Quek C.H., Mao H.Q., Xu X., Shen L., Ng M.L., Leong K.W., Yu H. Multi-layered microcapsules for cell encapsulation. Biomaterials 2002, 23:849-856.
215. Lahooti S., Sefton M.V. Effect of an immobilization matrix and capsule membrane permeability on the viability of encapsulated HEK cells. Biomaterials 2000, 21:987-995.
216. Edamura K., Ohgawara H., Nasu K., Iwami Y., Sato A., Ishikawa S., Matsuki N., Ono K., Ogawa H., Sasaki N. Effect of the extracellular matrix on pancreatic endocrine cell function and its biocompatibility in dogs. Cell Transplant. 2001, 10:493-498.
217. Jorge-Herrero E., Fernandez P., Turnay J., Olmo N., Calero P., Garcia R., Freile I., Castillo-Olivares J.L. Influence of different chemical cross-linking treatments on the properties of bovine pericardium and collagen. Biomaterials 1999, 20:539-545.
218. Marinucci L., Lilli C., Guerra M., Belcastro S., Becchetti E., Stabellini G., Calvi E.M., Locci P. Biocompatibility of collagen membranes crosslinked with glutaraldehyde or diphenylphosphoryl azide: an in vitro study. J. Biomed. Mater. Res. A 2003, 67:504-509.
219. Vendruscolo C.W., Andreazza I.F., Ganter J.L., Ferrero C., Bresolin T.M. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline. Int. J. Pharm. 2005, 296:1-11.
220. Mendes A.C., Baran E.T., Pereira R.C., Azevedo H.S., Reis R.L. Encapsulation and survival of a chondrocyte cell line within xanthan gum derivative. Macromol. Biosci. 2012, 12:350-359.
221. Chellat F., Tabrizian M., Dumitriu S., Chornet E., Magny P., Rivard C.H., Yahia L. In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex. J. Biomed. Mater. Res. 2000, 51:107-116.
222. Chellat F., Tabrizian M., Dumitriu S., Chornet E., Rivard C.H., Yahia L. Study of biodegradation behavior of chitosan-xanthan microspheres in simulated physiological media. J. Biomed. Mater. Res. 2000, 53:592-599.
223. Becker A., Katzen F., Puhler A., Ielpi L. Xanthan gum biosynthesis and application: a biochemical/genetic perspective. Appl. Microbiol. Biotechnol. 1998, 50:145-152.
224. de Haan B.J., Rossi A., Faas M.M., Smelt M.J., Sonvico F., Colombo P., de Vos P. Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid. J. Biomed. Mater. Res. A 2011, 98:394-403.
225. Piskin E. Biodegradable polymers as biomaterials. J. Biomater. Sci. Polym. Ed. 1995, 6:775-795.
226. Gill I., Ballesteros A. Bioencapsulation within synthetic polymers (Part 1): sol-gel encapsulated biologicals. Trends Biotechnol. 2000, 18:282-296.
227. Gill I., Ballesteros A. Bioencapsulation within synthetic polymers (Part 2): non-sol-gel protein-polymer biocomposites. Trends Biotechnol. 2000, 18:469-479.
228. Hill R.S., Cruise G.M., Hager S.R., Lamberti F.V., Yu X., Garufis C.L., Yu Y., Mundwiler K.E., Cole J.F., Hubbell J.A., Hegre O.D., Scharp D.W. Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann. N. Y. Acad. Sci. 1997, 831:332-343.
229. Cruise G.M., Hegre O.D., Lamberti F.V., Hager S.R., Hill R., Scharp D.S., Hubbell J.A. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999, 8:293-306.
230. Bryant S.J., Bender R.J., Durand K.L., Anseth K.S. Encapsulating chondrocytes in degrading PEG hydrogels with high modulus: engineering gel structural changes to facilitate cartilaginous tissue production. Biotechnol. Bioeng. 2004, 86:747-755.
231. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002, 23:4315-4323.
232. Nuttelman C.R., Tripodi M.C., Anseth K.S. In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels. J. Biomed. Mater. Res. A 2004, 68:773-782.
233. Zalipsky S., Mullah N., Harding J.A., Gittelman J., Guo L., DeFrees S.A. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Bioconjug. Chem. 1997, 8:111-118.
234. Nguyen K.T., West J.L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002, 23:4307-4314.
235. Lin C.C., Metters A.T., Anseth K.S. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha. Biomaterials 2009, 30:4907-4914.
236. Cruise G.M., Scharp D.S., Hubbell J.A. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials 1998, 19:1287-1294.
237. Hubbell J.A., Pathak C.P., Sawhney A.S., Desai N.P., Hossainy S.F.A. Gels for encapsulation of biological materials, in, Ca, USA 2004.
238. Chang S.J., Lee C.H., Hsu C.Y., Wang Y.J. Biocompatible microcapsules with enhanced mechanical strength. J. Biomed. Mater. Res. A 2002, 59:118-126.
239. Sabnis A., Rahimi M., Chapman C., Nguyen K.T. Cytocompatibility studies of an in situ photopolymerized thermoresponsive hydrogel nanoparticle system using human aortic smooth muscle cells. J. Biomed. Mater. Res. A 2009, 91:52-59.
240. Cellesi F., Tirelli N., Hubbell J.A. Towards a fully-synthetic substitute of alginate: development of a new process using thermal gelation and chemical cross-linking. Biomaterials 2004, 25:5115-5124.
241. Cellesi F., Tirelli N. A new process for cell microencapsulation and other biomaterial applications: thermal gelation and chemical cross-linking in "tandem". J. Mater. Sci. Mater. Med. 2005, 16:559-565.
242. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23:47-55.
243. Nuttelman C.R., Rice M.A., Rydholm A.E., Salinas C.N., Shah D.N., Anseth K.S. Macromolecular monomers for the synthesis of hydrogel niches and their application in cell encapsulation and tissue engineering. Prog. Polym. Sci. 2008, 33:167-179.
244. Andrade J.D., Hlady V. Plasma protein adsorption: the big twelve. Ann. N. Y. Acad. Sci. 1987, 516:158-172.
245. Sawhney A.S., Pathak C.P., Hubbell J.A. Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. Biomaterials 1993, 14:1008-1016.
246. Jang J.Y., Lee D.Y., Park S.J., Byun Y. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Biomaterials 2004, 25:3663-3669.
247. Cheung C.Y., Anseth K.S. Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug. Chem. 2006, 17:1036-1042.
248. Emerich D.F., Winn S.R., Harper J., Hammang J.P., Baetge E.E., Kordower J.H. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J. Comp. Neurol. 1994, 349:148-164.
249. Emerich D.F., Winn S.R., Hantraye P.M., Peschanski M., Chen E.Y., Chu Y., McDermott P., Baetge E.E., Kordower J.H. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 1997, 386:395-399.
250. Emerich D.F., Winn S.R., Lindner M.D. Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents. Cell Transplant. 1996, 5:589-596.
251. Iwata H., Amemiya H., Hayashi R., Fujii S., Akutsu T. The use of photocrosslinkable polyvinyl alcohol in the immunoisolation of pancreatic islets. Transplant. Proc. 1990, 22:797-799.
252. Hymer W.C., Wilbur D.L., Page R., Hibbard E., Kelsey R.C., Hatfield J.M. Pituitary hollow fiber units in vivo and in vitro. Neuroendocrinology 1981, 32:339-349.
253. Dulieu C., Bazile D. Influence of lipid nanocapsules composition on their aptness to freeze-drying. Pharm. Res. 2005, 22:285-292.
254. Vrana N.E., O'Grady A., Kay E., Cahill P.A., McGuinness G.B. Cell encapsulation within PVA-based hydrogels via freeze-thawing: a one-step scaffold formation and cell storage technique. J. Tissue. Eng. Regen. Med. 2009, 3:567-572.
255. Qi M., Gu Y., Sakata N., Kim D., Shirouzu Y., Yamamoto C., Hiura A., Sumi S., Inoue K. PVA hydrogel sheet macroencapsulation for the bioartificial pancreas. Biomaterials 2004, 25:5885-5892.
256. Qi Z., Shen Y., Yanai G., Yang K., Shirouzu Y., Hiura A., Sumi S. The in vivo performance of polyvinyl alcohol macro-encapsulated islets. Biomaterials 2010, 31:4026-4031.
257. Winn S.R., Lindner M.D., Lee A., Haggett G., Francis J.M., Emerich D.F. Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences. Exp. Neurol. 1996, 140:126-138.
258. Chick W.L., Perna J.J., Lauris V., Low D., Galletti P.M., Panol G., Whittemore A.D., Like A.A., Colton C.K., Lysaght M.J. Artificial pancreas using living beta cells: effects on glucose homeostasis in diabetic rats. Science 1977, 197:780-782.
259. Aebischer P., Wahlberg L., Tresco P.A., Winn S.R. Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. Biomaterials 1991, 12:50-56.
260. Maki T., O'Neil J.J., Porter J., Mullon C.J.P., Solomon B.A., Monaco A.P. Long-term function of porcine islets in xenogeneic hosts. Transplant. Proc. 1996, 28:807.
261. Mathews D.T., Birney Y.A., Cahill P.A., McGuinness G.B. Vascular cell viability on polyvinyl alcohol hydrogels modified with water-soluble and -insoluble chitosan. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 84:531-540.
262. Cascone M.G., Tricoli M., Cerrai P., Del Guerra R.S. Cell cultures in the biocompatibility study of synthetic materials. Cytotechnology 1993, 11:S137-S139.
263. Burczak K., Gamian E., Kochman A. Long-term in vivo performance and biocompatibility of poly(vinyl alcohol) hydrogel macrocapsules for hybrid-type artificial pancreas. Biomaterials 1996, 17:2351-2356.
264. Young T.H., Yao N.K., Chang R.F., Chen L.W. Evaluation of asymmetric poly(vinyl alcohol) membranes for use in artificial islets. Biomaterials 1996, 17:2139-2145.
265. Gentile F.T., Doherty E.J. Polymer science for macroencapsulation of cells for central nervous system transplantation. React. Polym. 1995, 25:207-227.
266. Shoichet M.S., Rein D.H. In vivo biostability of a polymeric hollow fibre membrane for cell encapsulation. Biomaterials 1996, 17:285-290.
267. Shoichet M.S., Winn S.R., Athavale S., Harris J.M., Gentile F.T. Poly(ethylene oxide)-grafted thermoplastic membranes for use as cellular hybrid bio-artificial organs in the central nervous system. Biotechnol. Bioeng. 1994, 43:563-572.
268. Tresco P.A., Bridge M.J. Ethanol treatment alters the ultrastructure and permeability of PAN-PVC hollow fiber cell encapsulation membranes. J. Membr. Sci. 2002, 195:51-64.
269. Tresco P.A., Bridge M.J., Broadhead K.W., Hlady V. Ethanol treatment alters the ultrastructure and permeability of PAN-PVC hollow fiber cell encapsulation membranes. J. Membr. Sci. 2002, 195:51-64.
270. Ward R.S., White K.A., Wolcott C.A., Wang A.Y., Kuhn R.W., Taylor J.E., John J.K. Development of a hybrid artificial pancreas with a dense polyurethane membrane. ASAIO J. 1993, 39:M261-M267.
271. Lamberton P., Lipsky M., McMillan P. Use of semipermeable polyurethane hollow fibers for pituitary organ culture. In Vitro Cell. Dev. Biol. 1988, 24:500-504.
272. Kim Y.T., Hitchcock R., Broadhead K.W., Messina D.J., Tresco P.A. A cell encapsulation device for studying soluble factor release from cells transplanted in the rat brain. J. Control. Release 2005, 102:101-111.
273. Seymour R.B., Kauffman G.B. Polyurethanes: a class of modern versatile materials. J. Chem. Educ. 1992, 69:909-914.
274. Kim H.N., Kang D.H., Kim M.S., Jiao A., Kim D.H., Suh K.Y. Patterning methods for polymers in cell and tissue engineering. Ann. Biomed. Eng. 2012, 40:1339-1355.
275. Soldani G., Losi P., Bernabei M., Burchielli S., Chiappino D., Kull S., Briganti E., Spiller D. Long term performance of small-diameter vascular grafts made of a poly(ether)urethane-polydimethylsiloxane semi-interpenetrating polymeric network. Biomaterials 2010, 31:2592-2605.
276. Khandwekar A.P., Patil D.P., Hardikar A.A., Shouche Y.S., Doble M. In vivo modulation of foreign body response on polyurethane by surface entrapment technique. J. Biomed. Mater. Res. A 2010, 95:413-423.
277. George S., Nair P.D., Risbud M.V., Bhonde R.R. Nonporous polyurethane membranes as islet immunoisolation matrices - biocompatibility studies. J. Biomater. Appl. 2002, 16:327-340.
278. Khandwekar A.P., Patil D.P., Hardikar A.A., Shouche Y.S., Doble M. In vivo modulation of foreign body response on polyurethane by surface entrapment technique. J. Biomed. Mater. Res. A 2010, 95A:413-423.
279. Petersen P., Lembert N., Stenglein S., Planck H., Ammon H.P., Becker H.D. Insulin secretion from cultured islets encapsulated in immuno- and virus-protective capillaries. Transplant. Proc. 2001, 33:3520-3522.
280. Deglon N., Heyd B., Tan S.A., Joseph J.M., Zurn A.D., Aebischer P. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum. Gene Ther. 1996, 7:2135-2146.
281. Schwenter F., Schneider B.L., Pralong W.F., Deglon N., Aebischer P. Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions. Hum. Gene Ther. 2004, 15:669-680.
282. Abe T., Kato K., Fujioka T., Akizawa T. The blood compatibilities of blood purification membranes and other materials developed in Japan. Int. J. Biomater. 2011, 2011:375390.
283. Lembert N., Wesche J., Petersen P., Doser M., Zschocke P., Becker H.D., Ammon H.P. Encapsulation of islets in rough surface, hydroxymethylated polysulfone capillaries stimulates VEGF release and promotes vascularization after transplantation. Cell Transplant. 2005, 14:97-108.
284. Lembert N., Wesche J., Petersen P., Zschocke P., Enderle A., Planck H., Ammon H.P. Macroencapsulation of rat islets without alteration of insulin secretion kinetics. Exp. Clin. Endocrinol. Diabetes 2001, 109:116-119.
285. Lembert N., Wesche J., Petersen P., Zschocke P., Enderle A., Planck H., Ammon H.P.T. Macroencapsulation of rat islets without alteration of insulin secretion kinetics. Exp. Clin. Endocrinol. Diabetes 2001, 109:116,119.
286. Guttinger M., Padrun V., Pralong W.F., Boison D. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp. Neurol. 2005, 193:53-64.
287. Xu X., Yang Y., Zhu N. Characteristics and molecular mechanism of adhesion proteins on reused hemodialysis membranes. Blood Purif. 2009, 27:321-329.
288. Takebe K., Shimura T., Munkhbat B., Hagihara M., Nakanishi H., Tsuji K. Xenogeneic (pig to rat) fetal liver fragment transplantation using macrocapsules for immunoisolation. Cell Transplant. 1996, 5:S31-S33.
289. Takebe K., Shimura T., Munkhbat B., Hagihara M., Nakanishi H., Tsuji K. Xenogeneic (pig to rat) fetal liver fragment transplantation using macrocapsules for immunoisolation. Cell Transplant. 1996, 5:S31-S33.
290. Granicka L.H., Kawiak J.W., Glowacka E., Werynski A. Encapsulation of OKT3 cells in hollow fibers. ASAIO J. 1996, 42:M863-M866.
291. Coates G.W., Waymouth R.M. Oscillating stereocontrol: a strategy for the synthesis of thermoplastic elastomeric polypropylene. Science 1995, 267:217-219.
292. Granicka L.H., Kawiak J., Snochowski M., Wojcicki J.M., Sabalinska S., Werynski A. Polypropylene hollow fiber for cells isolation: methods for evaluation of diffusive transport and quality of cells encapsulation. Artif. Cells Blood Substit. Immobil. Biotechnol. 2003, 31:249-262.
293. Granicka L.H., Wdowiak M., Kosek A., Swiezewski S., Wasilewska D., Jankowska E., Werynski A., Kawiak J. Survival analysis of Escherichia coli encapsulated in a hollow fiber membrane in vitro and in vivo: preliminary report. Cell Transplant. 2005, 14:323-330.
294. Brown L.F., Detmar M., Claffey K., Nagy J.A., Feng D., Dvorak A.M., Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 1997, 79:233-269.
295. Sukhorukov G.B., Donath E., Moya S., Susha A.S., Voigt A., Hartmann J., Mohwald H. Microencapsulation by means of step-wise adsorption of polyelectrolytes. J. Microencapsul. 2000, 17:177-185.
296. Georgieva R., Moya S., Donath E., Baumler H. Permeability and conductivity of red blood cell templated polyelectrolyte capsules coated with supplementary layers. Langmuir 2004, 20:1895-1900.
297. Krol S., del Guerra S., Grupillo M., Diaspro A., Gliozzi A., Marchetti P. Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett. 2006, 6:1933-1939.
298. Gao C., Leporatti S., Moya S., Donath E., Mohwald H. Swelling and shrinking of polyelectrolyte microcapsules in response to changes in temperature and ionic strength. Chemistry 2003, 9:915-920.
299. Teramura Y., Iwata H. Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv. Drug Deliv. Rev. 2010, 62:827-840.
300. Iwata H., Murakami Y., Ikada Y. Control of complement activities for immunoisolation. Ann. N. Y. Acad. Sci. 1999, 875. (vol.).
301. Sefton M.V., May M.H., Lahooti S., Babensee J.E. Making microencapsulation work: conformal coating, immobilization gels and in vivo performance. J. Control. Release 2000, 65:173-186.
302. Lahooti S., Sefton M.V. Methods for microencapsulation with HEMA-MMA. Methods Mol. Med. 1999, 18:331-348.
303. Wells G.D., Fisher M.M., Sefton M.V. Microencapsulation of viable hepatocytes in HEMA-MMA microcapsules: a preliminary study. Biomaterials 1993, 14:615-620.
304. Uludag H., Sefton M.V. Metabolic activity of CHO fibroblasts in HEMA-MMA microcapsules. Biotechnol. Bioeng. 1992, 39:672-678.
305. Fleming A.J., Sefton M.V. Viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated PC12 cells after omental pouch implantation within agarose gels. Tissue Eng. 2003, 9:1023-1036.
306. Gharapetian H., Davies N.A., Sun A.M. Encapsulation of viable cells within polyacrylate membranes. Biotechnol. Bioeng. 1986, 28:1595-1600.
307. Sugamori M.E., Sefton M.V. Microencapsulation of pancreatic islets in a water insoluble polyacrylate. ASAIO Trans. 1989, 35:791-799.
308. Ronel S.H., D'Andrea M.J., Hashiguchi H., Klomp G.F., Dobelle W.H. Macroporous hydrogel membranes for a hybrid artificial pancreas. I. Synthesis and chamber fabrication. J. Biomed. Mater. Res. A 1983, 17:855-864.
309. Young T.H., Chuang W.Y., Yao N.K., Chen L.W. Use of a diffusion model for assessing the performance of poly(vinyl alcohol) bioartificial pancreases. J. Biomed. Mater. Res. A 1998, 40:385-391.
310. Stevenson W.T., Sefton M.V. Graft copolymer emulsions of sodium alginate with hydroxyalkyl methacrylates for microencapsulation. Biomaterials 1987, 8:449-457.
311. Uludag H., Horvath V., Black J.P., Sefton M.V. Viability and protein secretion from human hepatoma (HepG2) cells encapsulated in 400-μm polyacrylate microcapsules by submerged nozzle-liquid jet extrusion. Biotechnol. Bioeng. 1994, 44:1199-1204.
312. Babensee J.E., Anderson J.M., McIntire L.V., Mikos A.G. Host response to tissue engineered devices. Adv. Drug Deliv. Rev. 1998, 33:111-139.
313. Jeyanthi R., Rao K.P. In vivo biocompatibility of collagen-poly(hydroxyethyl methacrylate) hydrogels. Biomaterials 1990, 11:238-243.
314. Belkas J.S., Munro C.A., Shoichet M.S., Johnston M., Midha R. Long-term in vivo biomechanical properties and biocompatibility of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) nerve conduits. Biomaterials 2005, 26:1741-1749.
315. Babensee J.E., Sodhi R.N., Sefton M.V. X-ray photoelectron spectroscopy (XPS) surface analysis of HEMA-MMA microcapsules. J. Biomater. Sci. Polym. Ed. 1997, 8:655-665.
316. Babensee J.E., Sefton M.V. Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response. Tissue Eng. 2000, 6:165-182.
317. Feng M., Sefton M.V. Hydroxyethyl methacrylate-methyl methacrylate (HEMA-MMA) copolymers for cell microencapsulation: effect of HEMA purity. J. Biomater. Sci. Polym. Ed. 2000, 11:537-545.
318. Colton C.K. Engineering challenges in cell-encapsulation technology. Trends Biotechnol. 1996, 14:158-162.
319. Kessler L., Legeay G., Jesser C., Damge C., Pinget M. Influence of corona surface treatment on the properties of an artificial membrane used for Langerhans islets encapsulation: permeability and biocompatibility studies. Biomaterials 1995, 16:185-191.
320. Honiger J., Balladur P., Mariani P., Calmus Y., Vaubourdolle M., Delelo R., Capeau J., Nordlinger B. Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes. Biomaterials 1995, 16:753-759.
321. Prevost P., Flori S., Collier C., Muscat E., Rolland E. Application of AN69 hydrogel to islet encapsulation. Evaluation in streptozotocin-induced diabetic rat model. Ann. N. Y. Acad. Sci. 1997, 831:344-349.
322. Sevastianov V.I., Tseytlina E.A., Volkov A.V., Shumakov V.I. Importance of adsorption-desorption processes of plasma proteins in biomaterials hemocompatibility. Trans. Am. Soc. Artif. Intern. Organs 1984, 30. (vol.).
323. Kessler L., Aprahamian M., Keipes M., Damge C., Pinget M., Poinsot D. Diffusion properties of an artificial membrane used for Langerhans islets encapsulation: an in vitro test. Biomaterials 1992, 13:44-49.
324. Sigrist S., Mechine-Neuville A., Mandes K., Calenda V., Braun S., Legeay G., Bellocq J.P., Pinget M., Kessler L. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant. 2003, 12:627-635.
325. Prevost P.H., Flori S., Collier C., Muscat E., Rolland E. Application of AN69® hydrogel to islet encapsulation. Ann. N. Y. Acad. Sci. 1997, 831:344-349.
326. Kessler L., Jesser C., Lombard Y., Karsten V., Belcourt A., Pinget M., Poindron P. Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: in vivo and in vitro studies. J. Leukoc. Biol. 1996, 60:729-736.
327. Kessler L., Legeay G., West R., Belcourt A., Pinget M. Physicochemical and biological studies of corona-treated artificial membranes used for pancreatic islets encapsulation: mechanism of diffusion and interface modification. J. Biomed. Mater. Res. A 1997, 34:235-245.
328. Karen B., Shalaby S., Griet A. Polymer Biocompatibility and Toxicity, in: Absorbable and Biodegradable Polymers 2003, CRC Press.
329. de Vos P., Bucko M., Gemeiner P., Navratil M.n., Å vitel J., Faas M., Strand B.L.k., Skjak-Braek G., Morch Y.A., Vikartovska A., Lacik I., Kollarikova G., Orive G., Poncelet D., Pedraz J.L., Ansorge-Schumacher M.B. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009, 30:2559-2570.
330. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20:45-53.
331. Schmidt J.J., Rowley J., Kong H.J. Hydrogels used for cell-based drug delivery. J. Biomed. Mater. Res. A 2008, 87:1113-1122.
332. De Vos P., De Haan B.J., Van Schilfgaarde R. Upscaling the production of encapsulated islets. Biomaterials 1997, 18:1085-1090.
333. Schneider S., Feilen P.J., Kraus O., Haase T., Sagban T.A., Lehr H.A., Beyer J., Pommersheim R., Weber M.M. Biocompatibility of alginates for grafting: impact of alginate molecular weight. Artif. Cells Blood Substit. Immobil. Biotechnol. 2003, 31:383-394.
334. Orive G., Carcaboso A.M., Hernandez R.M., Gascon A.R., Pedraz J.L. Biocompatibility evaluation of different alginates and alginate-based microcapsules. Biomacromolecules 2005, 6:927-931.
335. Orive G., Hernandez R.M., Gascon A.R., Calafiore R., Chang T.M., De Vos P., Hortelano G., Hunkeler D., Lacik I., Shapiro A.M., Pedraz J.L. Cell encapsulation: promise and progress. Nat. Med. 2003, 9:104-107.
336. Iwamoto M., Kurachi M., Nakashima T., Kim D., Yamaguchi K., Oda T., Iwamoto Y., Muramatsu T. Structure-activity relationship of alginate oligosaccharides in the induction of cytokine production from RAW264.7 cells. FEBS Lett. 2005, 579:4423-4429.